
Advancing core workflows with the Intabio ZT system
This event is now available on demand
Event Overview:
Characterization of charge isoforms, whether in early product development or associated with licensure filings, is usually achieved through separate analytical techniques. Fraction collection via ion-exchange (IEX) liquid chromatography or iCE followed by mass spectrometry are typically used.
This webinar discusses opportunities to advance core platform technologies through a fully integrated icIEF-UV/MS workflow on the Intabio ZT system and how rapid post-translational modification (PTM) characterization of charge isoforms can be used to guide decisions during early development.
Key Learning Objectives:
• Identify sequence variants with icIEF-UV/MS
• Identify charge variants of AAVs with icIEF-UV/MS
• Incorporate icIEF-UV/MS into existing standard operating procedures
• Understand the impact rapid charge variant identification has on drug development
Who Should Attend:
• Analytical development scientists
• Process development scientists
• Cell line development scientists
• Protein characterization scientists
Featured Speaker

Kristen Nields, PhD
Principal Scientist
Johnson & Johnson Innovative
Medicine
